Children with hemoglobin E/β-thalassemia have a high risk of being vitamin D deficient even if they get abundant sun exposure: A study from Thailand

Pediatric Blood and Cancer

Volumn 60, Issue 10, 2013, Pages 1683-1688

  Nakavachara, Pairunyar ^a   Viprakasit, Vip ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hemoglobinopathies; Thalassemia; Vitamin D deficiency

Indexed keywords

HEMOGLOBIN E; VITAMIN D;

ADOLESCENT; ARTICLE; CHILD; CLIMATE; FEMALE; GENE MUTATION; GENETIC SCREENING; GEOGRAPHY; HEMOGLOBIN ANALYSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUN EXPOSURE; THAILAND; THALASSEMIA MAJOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

HEMOGLOBINOPATHIES; THALASSEMIA; VITAMIN D DEFICIENCY;

ADOLESCENT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMOGLOBIN E; HUMANS; MALE; THAILAND; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84881533685     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24614     Document Type: Article

References (40)

1. Brehm JM, Celedon JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009; 179:765-771.
2. Brehm JM, Acosta-Perez E, Klei L, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am J Respir Crit Care Med 2012; 186:140-146.
3. Holick MF. Vitamin D status: Measurement, interpretation, and clinical application. Ann Epidemiol 2009; 19:73-78.
4. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78:1193-1231.
5. McBeth J, Pye SR, O'Neill TW, et al. Musculoskeletal pain is associated with very low levels of vitamin D in men: Results from the European Male Ageing Study. Ann Rheum Dis 2010; 69:1448-1452.
6. Yang S, Smith C, DeLuca HF. 1 alpha, 25-dihydroxyvitamin D3 and 19-nor-1 alpha, 25-dihydroxyvitamin D2 suppress immunoglobulin production and thymic lymphocyte proliferation in vivo. Biochim Biophys Acta 1993; 1158:279-286.
7. Yang S, Smith C, Prahl JM, et al. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 1993; 303:98-106.
8. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008; 122:1142-1152.
9. Claster S, Wood JC, Noetzli L, et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol 2009; 84:344-348.
10. Fung EB, Aguilar C, Micaily I, et al. Treatment of vitamin D deficiency in transfusion-dependent thalassemia. Am J Hematol 2011; 86:871-873.
11. Moulas A, Challa A, Chaliasos N, et al. Vitamin D metabolites (25-hydroxyvitamin D, 24, 25 dihydroxyvitamin D and 1, 25-dihydroxyvitamin D) and osteocalcin in beta-thalassaemia. Acta Paediatr 1997; 86:594-599.
12. Napoli N, Carmina E, Bucchieri S, et al. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia. Bone 2006; 38:888-892.
13. Vogiatzi MG, Macklin EA, Fung EB, et al. Bone disease in thalassemia: A frequent and still unresolved problem. J Bone Miner Res 2009; 24:543-557.
14. Wood JC, Claster S, Carson S, et al. Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major. Br J Haematol 2008; 141:891-894.
15. Doulgeraki A, Athanasopoulou H, Voskaki I, et al. Bone health evaluation of children and adolescents with homozygous beta-thalassemia: Implications for practice. J Pediatr Hematol Oncol 2012; 34:344-348.
16. Pirinccioglu AG, Akpolat V, Koksal O, et al. Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone 2011; 49:819-823.
17. Anapliotou ML, Kastanias IT, Psara P, et al. The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: New therapeutic approaches. Clin Endocrinol (Oxf) 1995; 42:279-287.
18. Vogiatzi MG, Macklin EA, Fung EB, et al. Prevalence of fractures among the thalassemia syndromes in North America. Bone 2006; 38:571-575.
19. Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol 2009; 146:546-556.
20. Haidar R, Musallam KM, Taher AT. Bone disease and skeletal complications in patients with beta thalassemia major. Bone 2011; 48:425-432.
21. Viprakasit V, Chan LL, Chong QT, et al. Iron chelation therapy in the management of thalassemia: The Asian perspectives. Int J Hematol 2009; 90:435-445.
22. Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: A common & clinically diverse disorder. Indian J Med Res 2011; 134:522-531.
23. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121:297-300.
24. Kosulwat V. The nutrition and health transition in Thailand. Public Health Nutr 2002; 5:183-189.
25. Chailurkit L, Aekplakorn W, Ongphiphadhanakul B. Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health 2011; 11:853-860.
26. Tsitoura S, Amarilio N, Lapatsanis P, et al. Serum 25-hydroxyvitamin D levels in thalassaemia. Arch Dis Child 1978; 53:347-348.
27. Zamboni G, Marradi P, Tagliaro F, et al. Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major. Eur J Pediatr 1986; 145:133-136.
28. Dandona P, Menon RK, Houlder S, et al. Serum 1, 25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major. Arch Dis Child 1987; 62:474-477.
29. Rioja L, Girot R, Garabedian M, et al. Bone disease in children with homozygous beta-thalassemia. Bone Miner 1990; 8:69-86.
30. De Vernejoul MC, Girot R, Gueris J, et al. Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocrinol Metab 1982; 54:276-281.
31. Meguro S, Tomita M, Katsuki T, et al. Plasma 25-hydroxyvitamin d is independently associated with hemoglobin concentration in male subjects with type 2 diabetes mellitus. Int J Endocrinol 2011; 2011:362981.
32. Sim JJ, Lac PT, Liu IL, et al. Vitamin D deficiency and anemia: A cross-sectional study. Ann Hematol 2010; 89:447-452.
33. Abdul-Razzak KK, Khoursheed AM, Altawalbeh SM, et al. Hb level in relation to vitamin D status in healthy infants and toddlers. Public Health Nutr 2012; 15:1683-1687.
34. Jackson TC, Krauss MJ, DeBaun MR, et al. Vitamin D deficiency and comorbidities in children with sickle cell anemia. Pediatr Hematol Oncol 2012; 29:261-266.
35. Yoon JW, Kim SW, Yoo EG, et al. Prevalence and risk factors for vitamin D deficiency in children with iron deficiency anemia. Korean J Pediatr 2012; 55:206-211.
36. Taher AT, Musallam KM, Cappellini MD, et al. Optimal management of beta thalassaemia intermedia. Br J Haematol 2011; 152:512-523.
37. Pakbaz Z, Fischer R, Fung E, et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 2007; 49:329-332.
38. Chow LH, Frei JV, Hodsman AB, et al. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: Relation to iron status. Gastroenterology 1985; 88:865-869.
39. Fung EB, Xu Y, Trachtenberg F, et al. Inadequate dietary intake in patients with thalassemia. J Acad Nutr Diet 2012; 112:980-990.
40. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 2011; 98:53-58.